Investing
Comprehensive investing news, insights and opinions from the MoneyWeek team and the top voices in the investment sector. Covering market moves, the latest stock prices and the best funds and trusts to buy.
Explore Investing
-
What can Brazil’s World Cup squad tell us about investing in Asia?Sponsor Content Created With Aberdeen
By MoneyWeek Published
-
Fuller’s outperforms in a tough market – here's why it is worth buyingPub group Fuller’s continues to outperform despite headwinds in the hospitality sector. Should you buy its shares?
By Rupert Hargreaves Published
-
Will AI really wipe out all our jobs?How worried should we be about AI? Technological developments have always sparked fears of mass unemployment – but are those fears overdone?
By Stuart Watkins Published
-
High-quality and profitable companies in emerging marketsOpinion Three emerging market stocks, picked by Mark Hammonds, fund manager for the Guinness Emerging Markets Equity Income Fund
By Mark Hammonds Published
Opinion -
The best properties for sale with swimming poolsEight of the best properties for sale with swimming pools – from a New England-style house in Kent to a converted grain store in Warwickshire with a natural swimming pool.
By Natasha Langan Published
-
'Investors shouldn't sell Segro for short-term gain'Prologis's bid for Segro marks another milestone in the London Stock Exchange's decline. Its departure would be a dismal outcome for the UK, says Max King
By Max King Published
-
Worried about an AI bubble? These investment trusts could helpCapital spend on artificial intelligence infrastructure is coming under more scrutiny, but the sector still dominates passive indices.
By Dan McEvoy Published
-
Biotech's future looks bright – the best investments to buyBiotechnology companies are coming out of a dark period for the industry. Why has the tide turned, and is now a good time to buy in?
By David Prosser Published
-
The MoneyWeek ETF portfolio – July 2026 updateWe're updating our ETF portfolio – the outlook for the Middle East is still uncertain, but it rarely pays to sit on the sidelines indefinitely.
By Cris Sholto Heaton Published




